Glyceryl Trinitrate Hospira Uk (Glyceryl Trinitrate)

Glyceryl trinitrate injectable solution is indicated for several acute cardiovascular conditions where rapid vasodilation is required to relieve myocardial oxygen demand and improve hemodynamics.

• Acute angina pectoris – relief of chest pain unresponsive to oral nitrates.
• Acute heart failure, particularly pulmonary edema – reduction of preload and afterload.
• Hypertensive emergencies – rapid blood pressure lowering when other agents are unsuitable.
• Controlled hypotension during surgical procedures – to provide a bloodless field.
• Management of myocardial ischemia during cardiac catheterisation or angioplasty – to prevent spasm and improve flow.

Adverse reactions to glyceryl trinitrate injection are primarily linked to its nitric‑oxide mediated vasodilation; they can be mild and transient or, in rare cases, clinically significant.

Common

• Headache – throbbing pain often occurring shortly after infusion.
• Flushing – warm sensation and redness of the skin.
• Mild hypotension – drop in blood pressure that usually resolves with dose adjustment.
• Reflex tachycardia – compensatory increase in heart rate.
• Nausea or vomiting – gastrointestinal discomfort without severe consequences.

Serious

• Severe hypotension – marked blood pressure fall that may require emergency intervention.
• Methemoglobinemia – elevated methemoglobin levels causing cyanosis and reduced oxygen delivery.
• Cardiac ischemia worsening – paradoxical increase in myocardial oxygen demand leading to chest pain.

When using glyceryl trinitrate injection, clinicians should observe several precautions to minimise risks and ensure safe administration.

• Continuously monitor blood pressure and heart rate throughout the infusion.
• Avoid use in patients with severe anemia or significant hypoxia.
• Exercise caution in individuals with increased intracranial pressure.
• Do not combine with phosphodiesterase‑5 inhibitors due to risk of profound hypotension.
• Adjust dosing in patients with recent myocardial infarction or unstable coronary disease.
• Consider hepatic impairment when determining infusion rates.
• Store the product according to manufacturer guidelines to maintain stability.

Glyceryl trinitrate can interact with other medications that affect vascular tone or nitric‑oxide pathways.

Avoid

• Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil) – risk of profound hypotension.
• Other potent vasodilators (e.g., nitroprusside, hydralazine) – additive blood pressure lowering.

Use with caution

• Beta‑blockers – may blunt reflex tachycardia but still require monitoring.
• Calcium channel blockers – combined effect on blood pressure.
• Antihypertensive agents (ACE inhibitors, ARBs) – cumulative hypotensive effect.
• General anaesthetics – may enhance vasodilation during surgery.